Endoscopic Stenting Versus Surgical Bypass for Low Bile Duct Obstruction by Cancer of the Pancreatic Head
- Status
- TERMINATED
- Phase
- NA
Clinical Trials Related to Pancreatic Cancer
Related studies linked through entity extraction aliases.
A Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- N/A
Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
IDO Inhibitor Study for Relapsed or Refractory Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Phase I/II Trial of Radiation, Avastin and Tarceva for Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01)
- Status
- COMPLETED
- Phase
- PHASE1
Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Abraxane Therapy in Patients With Pancreatic Cancer Who Failed First-Line Gemcitabine Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Proton Therapy for Unresectable Cancer (CA) of Pancreas
- Status
- COMPLETED
- Phase
- NA
Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers
- Status
- COMPLETED
- Phase
- N/A
Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Human Leukocyte Antigen-A*02:01-restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Standardization of Surgery on the Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Biomarker Identification Trial of Tarceva (Erlotinib) in Patients With Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2